For the Inventor, By the Inventor

Enter assignee name

Billerica, MA, United States of America

Exogenesis Corporation

USPTO Granted Patents = 36

% Expired Patents = 25.0

CIPO Patents = 2

EPO Patents = 20

Forward Citations = 152

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Sean R Kirkpatrick (28 out of 36 patents)

Richard C Svrluga (19 out of 22 patents)

Allen R Kirkpatrick (12 out of 22 patents)

4. Stephen M Blinn (9 out of 20 patents)

5. Michael J Walsh (7 out of 7 patents)

6. Laurence B Tarrant (7 out of 9 patents)

7. Joseph B Khoury (7 out of 11 patents)

8. Barry M Zide (3 out of 5 patents)

9. Kiet A Chau (2 out of 2 patents)

10. Son T Chau (2 out of 2 patents)

11. James G Bachand (1 out of 1 patent)

12. Vincent DiFilippo (1 out of 3 patents)

13. Stanley Harrison (1 out of 1 patent)

14. Thy Yam (1 out of 1 patent)

15. Joseph Khoury (0 patent)

36 patents: Sort by Forward Citations

1. 11735432 - Method and apparatus for forming substrate surfaces with exposed crystal lattice using accelerated neutral atom beam (2023-08-22),

2. 11698582 - Method for modifying the wettability and/or other biocompatibility characteristics of a surface of a biological material by the application of gas cluster ion beam technology and biological materials made thereby (2023-07-11),

3. 11101134 - Method and apparatus to eliminate contaminant particles from an accelerated neutral atom beam and thereby protect a beam target (2021-08-24),

4. 11048162 - Method and apparatus for neutral beam processing based on gas cluster ion beam technology (2021-06-29),

5. 11004692 - Method for ultra-shallow etching using neutral beam processing based on gas cluster ion beam technology (2021-05-11),

6. 10971324 - Treatment method for inhibiting platelet attachment and articles treated thereby (2021-04-06),

7. 10858732 - Method for neutral beam processing based on gas cluster ion beam technology and articles produced thereby (2020-12-08),

8. 10825685 - Method for neutral beam processing based on gas cluster ion beam technology and articles produced thereby (2020-11-03),

9. 10670960 - Enhanced high aspect ratio etch performance using accelerated neutral beams derived from gas-cluster ion beams (2020-06-02),

10. 10627352 - Methods and apparatus for employing an accelerated neutral beam for improved surface analysis (2020-04-21),

11. 10556042 - Drug delivery system and method of manufacturing thereof (2020-02-11),

12. 10539867 - Film and methods of forming same (2020-01-21),

13. 10342900 - Drug delivery system and method of manufacturing thereof (2019-07-09),

14. 10209617 - Treatment method for defect reduction in a substrate and substrates treated thereby (2019-02-19),

15. 10202684 - Method for neutral beam processing based on gas cluster ion beam technology and articles produced thereby (2019-02-12),

Exogenesis Corporation is a leading biotechnology company specializing in the development and commercialization of advanced regenerative medicine products. With a focus on innovative technologies, our team of scientists, engineers, and medical professionals is dedicated to improving patient outcomes and revolutionizing the field of regenerative medicine. Through our cutting-edge research and development efforts, we strive to address unmet medical needs and provide novel therapeutic solutions for a wide range of conditions. Visit our website to learn more about our groundbreaking discoveries and ongoing projects.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Exogenesis Corporation

36 Patents

#23 in Billerica, MA

#560 in Massachusetts

#9,495 in US

#18,697 in the World

Billerica, MA, United States of America

Exogenesis Corporation

Forward Citations = 152

14 inventors:

Sean R Kirkpatrick (28 out of 36 patents)

Richard C Svrluga (19 out of 22 patents)

Allen R Kirkpatrick (12 out of 22 patents)

4. Stephen M Blinn (9 out of 20 patents)

5. Michael J Walsh (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…